Science & Enterprise subscription

Follow us on Twitter

  • A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is co…
    about 11 hours ago
  • New post on Science and Enterprise: Genentech, Biotech Partner on Multiple Sclerosis #Science #Business
    about 11 hours ago
  • New contributed post on Science and Enterprise: Careers Where Banter And Fun Come Into Their Own
    about 16 hours ago
  • A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer's disease wil…
    about 1 day ago
  • New post on Science and Enterprise: Trial to Test App Alerting for Dementia-Linked Drugs #Science #Business
    about 1 day ago

Please share Science & Enterprise

In Case You Missed It …

(tigerlily713, Pixabay)

29 July 2018. Among our favorite stories on Science & Enterprise are when interesting science becomes a business opportunity. Last Wednesday, we reported on Convelo Therapeutics, a spin-off enterprise from Case Western Reserve University in Cleveland, commercializing research by its two geneticist founders that stimulate stem cells to replenish damaged myelin around nerve cells in the brain. Myelin is the waxy substance protecting nerve cells that gets destroyed by multiple sclerosis. The company emerged from stealth mode when the founders published papers in two Nature journals on Wednesday.

Here are other stories we covered last week:

*     *     *

Comments are closed.